{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:28:31Z","timestamp":1791106111659,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.nbd.2006.01.014","type":"journal-article","created":{"date-parts":[[2006,5,5]],"date-time":"2006-05-05T02:30:33Z","timestamp":1146796233000},"page":"44-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Alessia","family":"Tarditi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Camurri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Varani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Andrea","family":"Borea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Abbracchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.nbd.2006.01.014_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrn1386","article-title":"Experimental therapeutics in transgenic mouse models of Huntington's disease","volume":"5","author":"Beal","year":"2004","journal-title":"Nat. Rev., Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2006.01.014_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0512","article-title":"Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington's disease","volume":"10","author":"Blum","year":"2002","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.nbd.2006.01.014_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1474-4422(03)00411-3","article-title":"Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics","volume":"2","author":"Blum","year":"2003","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.nbd.2006.01.014_bib4","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1523\/JNEUROSCI.23-12-05361.2003","article-title":"A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists","volume":"23","author":"Blum","year":"2003","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.nbd.2006.01.014_bib5","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0028-3908(97)00139-1","article-title":"Neonatal cerebral hypoxia\u2013ischemia: the effect of adenosine receptor antagonists","volume":"36","author":"Bona","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2006.01.014_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0006-2952(94)00464-W","article-title":"Binding thermodynamics of adenosine A2A receptor ligands","volume":"49","author":"Borea","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2006.01.014_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.nbd.2006.01.014_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/glia.10243","article-title":"Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes","volume":"43","author":"Brambilla","year":"2003","journal-title":"Glia"},{"issue":"8","key":"10.1016\/j.nbd.2006.01.014_bib9","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2006.01.014_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","article-title":"Loss of normal huntingtin function: new developments in Huntington's disease research","volume":"24","author":"Cattaneo","year":"2001","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2006.01.014_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.nbd.2006.01.014_bib12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J. Neurosci."},{"issue":"1386","key":"10.1016\/j.nbd.2006.01.014_bib13","first-page":"981","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos. Trans. R. Soc. London, Ser. B Biol. Sci."},{"issue":"21","key":"10.1016\/j.nbd.2006.01.014_bib14","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1523\/JNEUROSCI.19-21-09192.1999","article-title":"A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice","volume":"19","author":"Chen","year":"1999","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.nbd.2006.01.014_bib15","doi-asserted-by":"crossref","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease","volume":"21","author":"Chen","year":"2001","journal-title":"J. Neurosci."},{"issue":"14","key":"10.1016\/j.nbd.2006.01.014_bib16","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1074\/jbc.M413279200","article-title":"cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues","volume":"280","author":"Chiang","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.nbd.2006.01.014_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","article-title":"CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model","volume":"93","author":"Chou","year":"2005","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.nbd.2006.01.014_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/cne.1334","article-title":"Differential gene expression of adenosine A1, A2A, A2b, and A3 receptors in the human enteric nervous system","volume":"439","author":"Christofi","year":"2001","journal-title":"J. Comp. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2006.01.014_bib19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00001756-199903170-00005","article-title":"Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats","volume":"10","author":"Corsi","year":"1999","journal-title":"NeuroReport"},{"issue":"11","key":"10.1016\/j.nbd.2006.01.014_bib20","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1097\/00001756-200008030-00048","article-title":"Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats","volume":"11","author":"Corsi","year":"2000","journal-title":"NeuroReport"},{"issue":"7","key":"10.1016\/j.nbd.2006.01.014_bib21","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/sj.bjp.0701507","article-title":"ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus","volume":"122","author":"Cunha","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.nbd.2006.01.014_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2006.01.014_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(00)00872-7","article-title":"Expression of the Huntingtin-associated protein 1 gene in the developing and adult mouse","volume":"282","author":"Dragatsis","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"5222","key":"10.1016\/j.nbd.2006.01.014_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.nbd.2006.01.014_bib25","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1523\/JNEUROSCI.13-12-05402.1993","article-title":"The striopallidal neuron: a main locus for adenosine\u2013dopamine interactions in the brain","volume":"13","author":"Ferre","year":"1993","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2006.01.014_bib26","doi-asserted-by":"crossref","first-page":"PL61","DOI":"10.1016\/0024-3205(94)00889-2","article-title":"CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil","volume":"55","author":"Gao","year":"1994","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.nbd.2006.01.014_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2004.05.008","article-title":"Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow","volume":"17","author":"Gianfriddo","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.nbd.2006.01.014_bib28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.nbd.2006.01.014_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.nbd.2006.01.014_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/1096-9861(20010312)431:3<331::AID-CNE1074>3.0.CO;2-W","article-title":"Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum","volume":"431","author":"Hettinger","year":"2001","journal-title":"J. Comp. Neurol."},{"issue":"17","key":"10.1016\/j.nbd.2006.01.014_bib31","doi-asserted-by":"crossref","first-page":"13838","DOI":"10.1074\/jbc.M008589200","article-title":"Activation of protein kinase A and atypical protein kinase C by A(2A) adenosine receptors antagonizes apoptosis due to serum deprivation in PC12 cells","volume":"276","author":"Huang","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.nbd.2006.01.014_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1009666707307","article-title":"Adenosine-induced cell death: evidence for receptor-mediated signalling","volume":"4","author":"Jacobson","year":"1999","journal-title":"Apoptosis"},{"issue":"Pt. 3","key":"10.1016\/j.nbd.2006.01.014_bib33","first-page":"505","article-title":"Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model","volume":"127","author":"Jarabek","year":"2004","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.nbd.2006.01.014_bib34","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.neurobiolaging.2003.04.003","article-title":"Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease","volume":"24","author":"Li","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.nbd.2006.01.014_bib35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.nbd.2006.01.014_bib36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0301-0082(99)00019-2","article-title":"The selective vulnerability of striatopallidal neurons","volume":"59","author":"Mitchell","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2006.01.014_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0003-2697(80)90515-1","article-title":"Ligand: a versatile computerized approach for the characterization of ligand binding systems","volume":"107","author":"Munson","year":"1980","journal-title":"Anal. Biochem."},{"issue":"5","key":"10.1016\/j.nbd.2006.01.014_bib38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"issue":"Pt. 5","key":"10.1016\/j.nbd.2006.01.014_bib39","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awg119","article-title":"Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study","volume":"126","author":"Pavese","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2006.01.014_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1749-6632.2001.tb03614.x","article-title":"Adenosine extracellular brain concentrations and role of A2A receptors in ischemia","volume":"939","author":"Pedata","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.nbd.2006.01.014_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(95)00679-6","article-title":"Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats","volume":"287","author":"Popoli","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.nbd.2006.01.014_bib42","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1523\/JNEUROSCI.22-05-01967.2002","article-title":"Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum","volume":"22","author":"Popoli","year":"2002","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.nbd.2006.01.014_bib43","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/jnr.20150","article-title":"Activation of adenosine A2A receptor protects sympathetic neurons against nerve growth factor withdrawal","volume":"77","author":"Ramirez","year":"2004","journal-title":"J. Neurosci. Res."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2006.01.014_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0006-8993(99)01489-4","article-title":"The intrastratial injection of an adenosine A(2) receptor antagonist prevents frontal cortex EEG abnormalities in a rat model of Huntington's disease","volume":"831","author":"Reggio","year":"1999","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.nbd.2006.01.014_bib45","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","article-title":"Wild type huntingtin protects from apoptosis upstream of caspase-3","volume":"20","author":"Rigamonti","year":"2000","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.nbd.2006.01.014_bib46","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.nbd.2006.01.014_bib47","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.110078997","article-title":"Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease","volume":"97","author":"Turmaine","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.nbd.2006.01.014_bib48","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1096\/fj.00-0730fje","article-title":"Aberrant amplification of A2A receptor signaling in striatal cells expressing mutant huntingtin","volume":"15","author":"Varani","year":"2001","journal-title":"FASEB J."},{"issue":"14","key":"10.1016\/j.nbd.2006.01.014_bib49","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1096\/fj.03-0079fje","article-title":"Aberrant A2A receptor function in peripheral blood cells in Huntington's disease","volume":"17","author":"Varani","year":"2003","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.nbd.2006.01.014_bib50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/hmg\/6.3.487","article-title":"HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system","volume":"6","author":"Wanker","year":"1997","journal-title":"Hum. Mol. Genet."},{"issue":"15","key":"10.1016\/j.nbd.2006.01.014_bib51","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","article-title":"Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract","volume":"273","author":"Wellington","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"58","key":"10.1016\/j.nbd.2006.01.014_bib52","first-page":"1","article-title":"Huntington disease: new insights on the role of huntingtin cleavage","author":"Wellington","year":"2000","journal-title":"J. Neural Transm., Suppl."},{"issue":"2","key":"10.1016\/j.nbd.2006.01.014_bib53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat. Genet."},{"issue":"5529","key":"10.1016\/j.nbd.2006.01.014_bib54","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996106000180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996106000180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:59:38Z","timestamp":1760849978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996106000180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0969996106000180"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2006.01.014","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2006.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}